The COVID-19 Therapeutics Watchlist

by Sam Sun

Of the hundreds of agents being tested, selects the drugs most likely to have a significant impact on patients with COVID-19. The Watchlist is dynamic, with new drugs added and current drugs dropping off whenever new data prompts the changes. Selection for the Watchlist is based primarily on clinical trial data, but also on compelling mechanisms of action, signals of efficacy in compassionate use programs, and practical considerations such as manufacturing and distribution capacity to meet worldwide demand. Nominations for the Watchlist or other comments can be sent anytime to [email protected]

Follow the Watchlist on for drug details and updates.

© 2022 inDemic Foundation. All Rights Reserved.